Company News

中文

中文

Media Center

CreatiPhage Great Achievement at the 2023 Maker in China Shanghai Competition

Recently, the 2023 Maker in China SME (Small Medium Enterprise) Innovation and Entrepreneurship Competition in Shanghai concluded. CreatiPhage participating for the first time, achieved remarkable results by winning the first place in the Life Health Track at the sub-competition level and eleventh place (Excellence Award) in the overall competition.

2024-03-25

More
CreatiPhage Recognized as Shanghai's Innovative SME

CreatiPhage was successfully selected as Shanghai's Innovative SMEs, known for their high level of specialization, strong innovation capabilities, and growth potential.

2024-03-25

More
Minhang biotech company leading the charge against antibiotic resistance

A biotech company in Minhang District's Xinzhuang Industrial Zone is trying to tackle antibiotic resistance by tapping the potential of bacteriophage (also known as phage, a group of viruses that infect bacteria).

2024-03-25

More
CreatiPhage's 2023 Highlights

Reflecting on 2023, CreatiPhage navigated through the seasons with significant moments worth remembering.

2024-03-25

More
CreatiPhage official Taobao store PHAGINK series phage products officially launched

CreatiPhage team in further study and verify a large number of patients on the basis of clinical pathogens, carefully selected the strong specificity, wide coverage of natural phage preparation, compared with conventional sanitizers, natural phage preparation formula pure, secure no dependence for home, office, hospital and other conventional sanitizers is not easy to carry out or not easy to carry out the application scenarios.

2024-03-27

More
Bacteriophage Pipeline Seminar on February 22, 2022.

On the afternoon of February 22, 2022, at 2:00 PM, the "Bacteriophage Therapy R&D Pipeline Seminar," co-hosted by Zhongshan Hospital affiliated with Fudan University, CreatiPhage , Shanghai Phage and Antimicrobial Resistance Research Institute, Ultraordinary (Shanghai) Medical Technology Co., Ltd., and Fenglin Medical Innovation, was successfully held at Zhongshan Hospital. The seminar invited over 20 experts and scholars from the field of bacteriophage research, as well as representatives from the Shanghai Center for Drug Evaluation and Inspection, the Shanghai Municipal Health Commission, and Zhongshan Hospital affiliated with Fudan University, to provide guidance.

2022-11-30

More
【Combating Antimicrobial Resistance】 The Genesis of Creation and Devouring - First Release of the Promotional Video!

2022-12-19

More
CreatiPhage contributes to the 2022 Bacteriophage Summit and will co-organize the 2023 International Bacteriophage Symposium.

On November 12th, the 2022 Bacteriophage Summit officially commenced online. The alliance is dedicated to establishing a multi-win model for the clinical application of bacteriophages, formulating and promoting industry practice guidelines and standards for bacteriophage clinical research and application, creating and optimizing the clinical research environment for innovative bacteriophage drugs and technologies, uniting industry forces for complementary advantages, cultivating industry talent, establishing a demonstration network for the clinical application of bacteriophage therapy, advancing the pharmaceutical industry, improving the survival rates and quality of life for patients with antimicrobial-resistant infections, and curbing the spread and dissemination of antimicrobial-resistant bacteria. As one of the founding members of the alliance, CreatiPhage proudly serves as the vice-chairman unit of the alliance, with the first secretariat of the alliance also being based at CreatiPhage.

2023-01-11

More
CreatiPhage & Wenzhou Capital | Jointly Building a New Platform, Partnering with CreatiPhage.

2023-02-15

More
CreatiPhage & Jiayi Medical jointly established the Phage Clinical Translation Signing Ceremony and the Phage Clinical Technology Center Inauguration.

2023-02-15

More

　 1 2 　

Prev 1/2 Next

Add: 3333 Huaning Road, Shanghai
Tel: 0086-400-668-7738

About

Introduction

History

Specialist

Investors
Platforms

cPhageBank

Intelligent Phage Screening

Synthetic Phages
Pipelines

NatPhages

SynPhages

Personalized Therapy

Infection Contain
Research

Alliance Phage of China

Research progress
Media

Company News

Phage News
Contact

Careers

Contact

Patient Access

Official account

©Shanghai ICP reserve No. 2022031782-1 CreatiPhage Biotechnology Co., Ltd. All rights reserved. Designed by JCE

Links

Phage Directory

                            
Home

Tel

Top